Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
US7319163B2 · kind B2 · utility
4Cited by
2References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 24, 2005 |
| Grant date | Jan 15, 2008 |
| Priority date | — |
| Expiry date | Jun 24, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to novel compounds which are thyroid receptor ligands, preferably antagonists, and to methods for using such compounds in the treatment of cardiac arrhythmias, thyrotoxicosis and subclinical hyperthyrodism.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.